High NEDA and No PIRA in Natalizumab-Treated Patients With Pediatric-Onset Multiple Sclerosis
Neurol Neuroimmunol Neuroinflamm. 2024 Sep;11(5):e200303. doi: 10.1212/NXI.0000000000200303. Epub 2024 Aug 14. ABSTRACT BACKGROUND AND OBJECTIVES: Although pediatric-onset multiple sclerosis (POMS) is characterized by a more …